Abstracts tagged "Health Assessment Questionnaire"

Abstract Number: 2364 • 2012 ACR/ARHP Annual Meeting
CROSS-Sectional Assessment of Damage in Takayasu Arteritis with A Validated Tool
Ahmet Omma¹, Burak Erer², Omer Karadag³, Neslihan Yilmaz⁴, Fatma Alibaz-Oner⁵, Fatih Yildiz⁶, Melike Kalfa⁷, Gezmis Kimyon⁸, Sedat Kiraz⁹, Haner Direskeneli⁵, Eren Erken¹⁰, Kenan Aksu¹¹, Ahmet Mesut Onat¹², Ahmet Gul², Lale Ocal², Murat Inanc² and Sevil Kamali¹³, ¹Internal Medicine Department, Rheumatology Division, Istanbul University, Istanbul Faculty of Medicine, Istanbul, Turkey, ²Department of Internal Medicine, Rheumatology Division, Istanbul University, Istanbul Faculty of Medicine, Istanbul, Turkey, ³Rheumatology, Hacettepe University Faculty of Medicine, Ankara, Turkey, ⁴Department of Rheumatology, Bilim University Faculty of Medicine, Istanbul, Turkey, ⁵Division of Rheumatology, Department of Internal Medicine, Marmara University, Faculty of Medicine, Istanbul, Turkey, ⁶Rheumatology, Cukurova University, School of Medicine, Adana, Turkey, ⁷Dept. of Internal Medicine, Division of Rheumatology, Ege University, Faculty of Medicine, Izmir, Turkey, ⁸Department of Rheumatology, Gaziantep University School of Medicine, Gaziantep, Turkey, ⁹Division of Rheumatology, Department of Internal Medicine, Hacettepe University, Faculty of Medicine, Ankara, Turkey, ¹⁰Rheumatology, Cukurova University School of Medicine, Adana, Turkey, ¹¹Rheumatology, Ege University School of Medicine, Izmir, Turkey, ¹²Rheumatology, Gaziantep University School of Medicine, Gaziantep, Turkey, ¹³Department of Internal Medicine, Division of Rheumatology, Istanbul University, Istanbul Faculty of Medicine, Istanbul, Turkey
Background/Purpose: Takayasu arteritis (TA) is a large vessel vasculitis with a chronic course, usually causing damage by the time of diagnosis. To our knowledge, there…
Abstract Number: 2139 • 2012 ACR/ARHP Annual Meeting
Smoking Is Associated with Worsening Functional Status Over Time in a Diverse Cohort of Patients with Rheumatoid Arthritis
Matthew Reimert¹, Laura Trupin², Patricia P. Katz³, Edward H. Yelin⁴, Jennifer Barton² and John B. Imboden⁵, ¹Rheumatology, University of CA San Francisco, San Francisco, CA, ²Medicine, University of California, San Francisco, San Francisco, CA, ³Medicine, University of California San Francisco, San Francisco, CA, ⁴Medicine, UC San Francisco, San Francisco, CA, ⁵Department of Medicine, Division of Rheumatology, UCSF, San Francisco, CA
Background/Purpose: Although the effects of tobacco use on disease onset, severity, and response to therapy have been well studied in rheumatoid arthritis (RA), there is…
Abstract Number: 2068 • 2012 ACR/ARHP Annual Meeting
Is There a Difference in Rheumatology Patient Reported Outcomes When Measured At Home Versus the Clinic Setting?
C.J. Inman¹, Frederick Wolfe² and Kaleb Michaud³, ¹Pediatric Administration, University of Utah, Salt Lake City, UT, ²National Data Bank for Rheumatic Diseases, Wichita, KS, ³Rheumatology, National Data Bank for Rheumatic Diseases & University of Nebraska Medical Center, Omaha, NE
Background/Purpose: Registries have become a common tool for collecting patient-centered outcome measures. Clinical effectiveness research may be improved if data from multiple registries could be…
Abstract Number: 1957 • 2012 ACR/ARHP Annual Meeting
Prevalence and Associated Factors of Vitamin D Insufficiency and Deficiency in 4,793 Japanese Patients with Rheumatoid Arthritis
Takefumi Furuya¹, Takayuki Hosoi², Eiichi Tanaka³, Ayako Nakajima⁴, Atsuo Taniguchi⁵, Shigeki Momohara¹ and Hisashi Yamanaka¹, ¹Institute of Rheumatology, Tokyo Women's Medical University, Tokyo, Japan, ²Department of Clinical Research and Development, National Center for Geriatrics and Gerontology, Aichi, Japan, ³Tokyo Women's Medical University, Tokyo, Japan, ⁴Rheumatology, Institute of Rheumatology, Tokyo Women’s Medical University, Tokyo, Japan, ⁵Institute of Rheumatology, Tokyo Women’s Medical University, Tokyo, Japan
Background/Purpose: Vitamin D (25[OH]D) insufficiency and deficiency is reported to be common in patients with rheumatoid arthritis (RA) and is associated with increased disease activity…
Abstract Number: 1575 • 2012 ACR/ARHP Annual Meeting
The Impact of Targeted Exercise Intervention On Health Outcomes in Rheumatoid Arthritis
Laura J. Durcan¹, Fiona Wilson², Finbar (Barry) D. O'Shea³ and Gaye Cunnane⁴, ¹Rheumatology, Mater Misercordiae University Hospital, Dublin 7, Ireland, ²Physiotherapy, Trinity College Dublin, Dublin, Ireland, ³Rheumatology Dept, St James's Hospital, Dublin, Ireland, ⁴Dept of Rheumatology, St James's Hospital, Dublin, Ireland
Background/Purpose: Increased morbidity and mortality are recognized consequences of rheumatoid arthritis (RA). In addition to chronic inflammation, reduced physical activity may contribute to adverse outcomes…
Abstract Number: 1556 • 2012 ACR/ARHP Annual Meeting
The Effect of Ginger Therapy On Symptoms of Osteoarthritis: An Open Pilot Study
Tessa Therkleson, Nursing, Edith Cowan University, Perth, Australia
Background/Purpose: Osteoarthritis (OA) is a painful, progressive disease of synovial joints characterised by deterioration of cartilage and bone and inflammation. Osteoarthritis of the knee and…
Abstract Number: 1437 • 2012 ACR/ARHP Annual Meeting
Majority of Lupusqol Domains Are Negatively Correlated with Systemic Lupus Activity Questionnaire (SLAQ) Score
Wendy Marder¹, Martha Ganser¹, Margaret Hyzy² and Emily C. Somers³, ¹Division of Rheumatology, University of Michigan, Ann Arbor, MI, ²Internal Medicine, Universitiy of Michigan, Ann Arbor, MI, ³IntMed, Environmental Health, and OB/GYN, University of Michigan, Ann Arbor, MI
Background/Purpose: Systemic lupus erythematosus (SLE) disease activity measures such as the SLEDAI and BILAG require real time physician and laboratory assessment of patients, making them…
Abstract Number: 1411 • 2012 ACR/ARHP Annual Meeting
Equivalence of Various Language Versions of Lupus Specific Patient Reported Outcomes Measure (LupusPRO)
Meenakshi Jolly¹, Mark Kosinski², Sergio M.A. Toloza³, Joel A. Block⁴, Rachel A. Mikolaitis⁴, Sergio Durán-Barragan⁵, Ana M. Bertoli⁶, Ivana Blazevic⁷, Luis M. Vila⁸, Dilrukshie Cooray⁹, Emmanuel P. Katsaros¹⁰, Karina Marianne D. Torralba¹¹, Ioana Moldovan¹², Arif Kaya¹³, Berna Goker¹³, Seminur Haznedaroglu¹⁴, Mehmet E. Tezcan¹³, Josiane Bourré-Tessier¹⁵, Sasha Bernatsky¹⁶, Ann E. Clarke¹⁷, Michael H. Weisman¹⁸, Sandra V. Navarra¹⁹, Daniel J. Wallace²⁰ and Graciela S. Alarcon²¹, ¹Rheumatology, Rush University Medical Center, Chicago, IL, ²QualityMetric Inc, Lincoln, RI, ³Medicine, Hospital San Juan Bautista, Catamarca, Argentina, ⁴Section of Rheumatology, Rush University Medical Center, Chicago, IL, ⁵Unidad de Investigacion en Enfermedades Cronico-Degenerativas, Guadalajara, Mexico, ⁶Instituto Reumatológico Strusberg, Cordoba, Cordoba, Argentina, ⁷University of Buenos Aires, Buenos Aries, Argentina, ⁸Department of Medicine, Division of Rheumatology, University of Puerto Rico Medical Sciences Campus, San Juan, PR, ⁹Rheumatology, Harbor UCLA Medical Center, Torrance, CA, ¹⁰Int Medicine, Loma Linda Univ, Loma Linda, CA, ¹¹Rheumatology/Int Med, USC Keck Schl of Medicine, Los Angeles, CA, ¹²Loma Linda Univ Medical Center, Loma Linda, CA, ¹³Internal Medicine-Rheumatology, Gazi University Medical School, Ankara, Turkey, ¹⁴Internal Medicine-Rheumatology, Gazi University School of Medicine, Ankara, Turkey, ¹⁵Rheumatology, McGill University, Montréal, QC, Canada, ¹⁶Clinical Epidemiology, Research Institute of the McGill University Health Ctre, Montreal, QC, Canada, ¹⁷Division of Rheumatology, University of Calgary, Alberta, Calgary, AB, Canada, ¹⁸Rheumatology, Cedars-Sinai Medical Center, Los Angeles, CA, ¹⁹University of Santo Tomas Hospital, Manila, Philippines, ²⁰Cedars-Sinai Medical Center, Los Angeles, CA, ²¹Medicine, University of Alabama at Birmingham, Birmingham, AL
Background/Purpose: Due to observed disparities in health outcomes in Systemic Lupus Erythematosus (SLE) across racial/ethnic groups, socioeconomic status, or health care systems, studies on group…
Abstract Number: 1376 • 2012 ACR/ARHP Annual Meeting
Development of A Health Index for Patients with Ankylosing Spondylitis – First Steps of A Global Initiative Based On the ICF Guided by ASAS
Uta Kiltz¹, Désirée van der Heijde², Annelies Boonen³, Alarcos Cieza⁴, Gerold Stucki⁵, Muhammad Asim Khan⁶, Walter P. Maksymowych⁷, Helena Marzo-Ortega⁸, John D. Reveille⁹, William Taylor¹⁰, Cristina Bostan¹¹ and Jürgen Braun¹, ¹Rheumazentrum Ruhrgebiet, Herne, Germany, ²Rheumatology, Leiden University Medical Center, Leiden, Netherlands, ³Department of Internal Medicine, Division of Rheumatology, Maastricht University Medical Center, Maastricht, Netherlands, ⁴Munich, Germany, ⁵University of Lucerne, Lucerne, Switzerland, ⁶Medicine/ Rheumatology, CASE at MetroHealth Med Center, Cleveland, OH, ⁷Department of Medicine, University of Alberta, Edmonton, AB, Canada, ⁸Leeds Musculoskeletal Biomedical Research Unit and University of Leeds, Leeds, United Kingdom, ⁹Internal Medicine/Rheumatology, Univ of Texas Health Science Center at Houston, Houston, TX, ¹⁰University of Otago, Wellington, New Zealand, ¹¹Paraplegic Research Unit, Nottwil, Switzerland
Background/Purpose: The burden of ankylosing spondylitis (AS) can be considerable. The patients suffer from pain, stiffness and fatigue, and they are limited in their activities…
Abstract Number: 1345 • 2012 ACR/ARHP Annual Meeting
Validation of the Health Assessment Questionnaire for Spondyloarthritis in Patients with Non-Radiographic Axial Spondyloarthritis
Dennis Revicki¹, Wen-Hung Chen¹, Ying Jin¹, Sumati Rao², Philip J. Mease³ and Mary Cifaldi², ¹United Biosource Corporation, Bethesda, MD, ²Abbott Laboratories, Abbott Park, IL, ³Swedish Rheumatology Research Group, Seattle, WA
Background/Purpose: To evaluate the psychometric properties of the Health Assessment Questionnaire for Spondyloarthritis (HAQ-S) in patients with non-radiographic axial spondyloarthritis (nr-axSpA). Methods: Data from 185…
Abstract Number: 1353 • 2012 ACR/ARHP Annual Meeting
Improvement in Physical Function, Health-Related Quality of Life, and Work Productivity with Adalimumab Treatment in Nonradiographic Axial Spa: Wk-52 Results From Ability-1
Désirée van der Heijde¹, Philip J. Mease², Aileen L. Pangan³, Sumati Rao⁴, Naijun Chen⁴ and Mary A. Cifaldi⁴, ¹Department of Rheumatology, Leiden University Medical Center, Leiden, Netherlands, ²Swedish Rheumatology Research Group, Seattle, WA, ³Abbott, Abbott Park, IL, ⁴Abbott Laboratories, Abbott Park, IL
Background/Purpose: To evaluate long-term effects of adalimumab (ADA) treatment on patient reported outcomes (PROs) in nonradiographic axial spondyloarthritis (nr-axSpA). Methods: Ability-1 is an ongoing Phase…
Abstract Number: 1326 • 2012 ACR/ARHP Annual Meeting
Efficacy of Different Biologic Agents for Improving Physical Function As Measured by the Health Assessment Questionnaire: A Meta-Analysis with Indirect Comparisons
Lillian J. Barra¹, Andrew Ha², Louise Sun³, Catarina Fonseca⁴ and Janet E. Pope⁵, ¹Medicine, Division of Rheumatology, Schulich School of Medicine and Dentistry, Western University, London, ON, Canada, ²The University of Toronto, Toronto, ON, Canada, ³University of Ottawa, Ottawa, ON, Canada, ⁴Universidade de Lisboa, Lisbon, Portugal, ⁵Medicine, Divsion of Rheumatology, Schulich School of Medicine and Dentistry, Western University, London, ON, Canada
Background/Purpose: The Health Assessment Questionnaire (HAQ) is a patient-centred, validated measure of physical function. It is predictive for disability, morbidity and mortality. The efficacy…
Abstract Number: 1274 • 2012 ACR/ARHP Annual Meeting
Relationship Between Morning Stiffness Duration and Severity, Pain Intensity, and Measures of Disease Activity in a 12 Week Efficacy Study of a Modified (Delayed-Release) Prednisone Plus Disease-Modifying Antirheumatic Drugs in Rheumatoid Arthritis
Frank Buttgereit¹, John R. Kirwan², Kenneth G. Saag³, Reike Alten⁴, Amy Grahn⁵, Patricia Rice⁶ and Maarten Boers⁷, ¹Charité - Universitätsmedizin Berlin, Berlin, Germany, ²Academic Rheumatology Unit, Bristol Royal Infirmary, Bristol, United Kingdom, ³Div Clinical Immun & Rheum, Univ of Alabama-Birmingham, Birmingham, AL, ⁴Charité Univ Medicine, Berlin, Germany, ⁵Clinical Development, Horizon Pharma, Inc, Deerfield, IL, ⁶Statistics, CliniRx Research, Naperville, IL, ⁷Epidemiology & Biostatistics, VU University Medical Center, Amsterdam, Netherlands
Background/Purpose: RA patients typically present with pain and morning stiffness (MS). MS is predictive of both functional disability and escalated RA care, but the best…
Abstract Number: 1225 • 2012 ACR/ARHP Annual Meeting
Self Reported Comorbidity Is Common in Early Inflammatory Arthritis and Associated with Poorer Function and Quality of Life and Greater Disease Activity: Results From the Canadian Early Arthritis Cohort
Carol A. Hitchon¹, Gilles Boire², Boulos Haraoui³, Edward Keystone⁴, Janet E. Pope⁵, Vivian P. Bykerk⁶ and Canadian Early Arthritis Cohort (CATCH) Investigators⁷, ¹University of Manitoba, Winnipeg, MB, Canada, ²Rheumatology Division, Centre Hospitalier Universitaire de Sherbrooke, Université de Sherbrooke, Sherbrooke, QC, Canada, ³Osteoarthritis Research Unit, University of Montreal Hospital Research Centre (CRCHUM), Montreal, QC, Canada, ⁴University of Toronto, Toronto, ON, Canada, ⁵Medicine/Rheumatology, St. Joseph Health Care London, University of Western Ontario, London, ON, Canada, ⁶Rheumatology, Hospital for Special Surgery, New York, NY, ⁷Toronto, Canada
Background/Purpose: Chronic comorbid medical conditions may contribute to poor outcomes in rheumatoid arthritis. The extent of comorbidity, in particular cardiovascular disease (CVD), may be related…
Abstract Number: 399 • 2012 ACR/ARHP Annual Meeting
Can Sustained Remission of Rheumatoid Arthritis Be Predicted? an Analysis From the Japanese National Database of Rheumatic Disease (NinJa)
Yoichiro Haji¹, Mitsumasa Kishimoto¹, Ryo Rokutanda¹, Sachiko Ohde², Gautam A. Deshpande³, Yuri Ohara¹, Chisun Min¹, Yasuhiro Suyama¹, Hisanori Shimizu¹, Ken-ichi Yamaguchi¹, Akira Takeda⁴, Yukio Matsui¹, Masato Okada¹ and Shigeto Tohma⁵, ¹Division of Allergy & Rheumatology, St. Luke's International Hospital, Tokyo, Japan, ²Center for Clinical Epidemiology, St.Luke's Life of Science Institute, Tokyo, Japan, ³Center for Clinical Epidemiology, St. Luke's Life Science Instutute, Tokyo, Japan, ⁴Division of Clinical Immunology & Rheumatology, International University of Health and Welfare Hospital, Nasu-shiobara, Japan, ⁵Clinical Research Center for Allergy and Rheumatology, Sagamihara Hospital, National Hospital Organization, Sagamihara, Japan
Background/Purpose: Achievement of clinical remission in rheumatoid arthritis (RA) is now the goal of therapy to reduce joint damage and disability, and maintain or improve…

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].